DHX9 and Ewing sarcoma: Similar results were also obtained in SK-N-MC and LAP-35 Ewing sarcoma cells (Supplementary Figure S3), even though HNRNPM and SRSF3 knockdown in LAP-35 weakly affected DHX9 alternative splicing.